SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-036134
Filing Date
2011-04-15
Accepted
2011-04-15 17:06:36
Documents
15
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K b84103e10vk.htm 10-K 994645
2 EX-21.1 b84103exv21w1.htm EX-21.1 1460
3 EX-23.1 b84103exv23w1.htm EX-23.1 1275
4 EX-31.1 b84103exv31w1.htm EX-31.1 7938
5 EX-31.2 b84103exv31w2.htm EX-31.2 7940
6 EX-32.1 b84103exv32w1.htm EX-32.1 2327
7 GRAPHIC b84103b8410301.gif GRAPHIC 13172
8 GRAPHIC b84103b8410308.gif GRAPHIC 6017
9 GRAPHIC b84103b8410309.gif GRAPHIC 6279
10 GRAPHIC b84103b8410302.gif GRAPHIC 6997
11 GRAPHIC b84103b8410303.gif GRAPHIC 2602
12 GRAPHIC b84103b8410304.gif GRAPHIC 10297
13 GRAPHIC b84103b8410305.gif GRAPHIC 20522
14 GRAPHIC b84103b8410306.gif GRAPHIC 59476
15 GRAPHIC b84103b8410307.gif GRAPHIC 22127
  Complete submission text file 0000950123-11-036134.txt   1221081
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33958 | Film No.: 11763508
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences